Affiliations 

  • 1 Centre for Pathology Diagnostic and Research Laboratories (CPDRL), UniversitiTeknologi MARA (UiTM), Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia
  • 2 Centre for Pathology Diagnostic and Research Laboratories (CPDRL), UniversitiTeknologi MARA (UiTM), Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia; Cluster for Pathology and Laboratory Medicine, UniversitiTeknologi MARA (UiTM), Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia
  • 3 Primary Care Medicine Discipline, UniversitiTeknologi MARA (UiTM), Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia
  • 4 Discipline of Population Health and Preventive Medicine, Faculty of Medicine, UniversitiTeknologi MARA (UiTM), Sungai Buloh Campus, Sungai Buloh, Selangor, Malaysia
PLoS One, 2015;10(1):e0116867.
PMID: 25614985 DOI: 10.1371/journal.pone.0116867

Abstract

BACKGROUND: Inflammation, endothelial activation and oxidative stress have been established as key events in the initiation and progression of atherosclerosis. High-density lipoprotein cholesterol (HDL-c) is protective against atherosclerosis and coronary heart disease, but its association with inflammation, endothelial activation and oxidative stress is not well established.

OBJECTIVES: (1) To compare the concentrations of biomarkers of inflammation, endothelial activation and oxidative stress in subjects with low HDL-c compared to normal HDL-c; (2) To examine the association and correlation between HDL-c and these biomarkers and (3) To determine whether HDL-c is an independent predictor of these biomarkers.

METHODS: 422 subjects (mean age±SD = 43.2±11.9 years) of whom 207 had low HDL-c concentrations (HDL-c <1.0 mmol/L and <1.3 mmol/L for males and females respectively) and 215 normal controls (HDL-c ≥1.0 and ≥1.3 mmol/L for males and females respectively) were recruited in this study. The groups were matched for age, gender, ethnicity, smoking status, diabetes mellitus and hypertension. Fasting blood samples were collected for analysis of biomarkers of inflammation [high-sensitivity C-reactive protein (hsCRP) and Interleukin-6 (IL-6)], endothelial activation [soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), soluble Intercellular Adhesion Molecule-1 (sICAM-1) and E-selectin)] and oxidative stress [F2-Isoprostanes, oxidized Low Density Lipoprotein (ox-LDL) and Malondialdehyde (MDA)].

RESULTS: Subjects with low HDL-c had greater concentrations of inflammation, endothelial activation and oxidative stress biomarkers compared to controls. There were negative correlations between HDL-c concentration and biomarkers of inflammation (IL-6, p = 0.02), endothelial activation (sVCAM-1 and E-selectin, p = 0.029 and 0.002, respectively), and oxidative stress (MDA and F2-isoprostane, p = 0.036 and <0.0001, respectively). Multiple linear regression analysis showed HDL-c as an independent predictor of IL-6 (p = 0.02) and sVCAM-1 (p<0.03) after correcting for various confounding factors.

CONCLUSION: Low serum HDL-c concentration is strongly correlated with enhanced status of inflammation, endothelial activation and oxidative stress. It is also an independent predictor for enhanced inflammation and endothelial activation, which are pivotal in the pathogenesis of atherosclerosis and atherosclerosis-related complications.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.